Yonsei Med J.  2019 Apr;60(4):389-394. 10.3349/ymj.2019.60.4.389.

Subcutaneous Immunotherapy in Patients with Fagales Pollen-Induced Oral Allergy Syndrome

• Kong N
• Kim S
• Lee SC
• Park KH
• Lee JH
• Park JW

• KMID: 2450195
• DOI: http://doi.org/10.3349/ymj.2019.60.4.389

Abstract

Oral allergy syndrome (OAS) is the most common food allergy-related condition in adults. This study aimed to investigate whether subcutaneous immunotherapy (SCIT) with Fagales pollen-containing extracts can improve the clinical symptoms of OAS in Korea. In total, 56 OAS patients were included: 19 subjects treated with SCIT, which included Fagales pollen extracts, and 37 not treated with immunotherapy (IT). We reviewed the patients' medical records and administered a telephone questionnaire at one point to assess baseline OAS features and changes in the patients' OAS and allergic rhinoconjunctivitis (ARC) symptoms after treatment. Only 12 patients who received SCIT and 15 patients that did not receive SCIT could report on changes in OAS symptoms after treatment because the other patients practiced strict avoidance of their culprit fruits and vegetables, and they could not respond to the status of OAS. SCIT reduced the severity of OAS (p=0.005). Nine of the 12 patients (75%) that received SCIT reported a more than 50% reduction in OAS symptoms. In contrast, only three of the 15 patients (20%) that did not receive IT reported more than a 50% reduction in OAS symptoms. SCIT also reduced the severity of ARC symptoms (p < 0.001). The results indicate that SCIT with Fagales pollen-containing extracts is associated with improved OAS symptoms in Korea.

Keyword

Oral allergy syndrome; subcutaneous immunotherapy; Fagales pollen

MeSH Terms

Adult
Fruit
Humans
Hypersensitivity*
Immunotherapy*
Korea
Medical Records
Pollen
Telephone
Vegetables

Figure

• 

  Fig. 1 Flow chart of inclusion and exclusion of participants. SCIT, subcutaneous immunotherapy; OAS, oral allergy syndrome.

Reference

1. Crespo JF, Rodriguez J. Food allergy in adulthood. Allergy. 2003; 58:98–113. PMID: 12622740.

2. Fernández-Rivas M, Benito C, González-Mancebo E, de Durana DA. Allergies to fruits and vegetables. Pediatr Allergy Immunol. 2008; 19:675–681. PMID: 19097271.

3. Lee SH, Ban GY, Jeong K, Shin YS, Park HS, Lee S, et al. A retrospective study of Korean adults with food allergy: differences in phenotypes and causes. Allergy Asthma Immunol Res. 2017; 9:534–539. PMID: 28913993.

4. Mauro M, Russello M, Incorvaia C, Gazzola G, Frati F, Moingeon P, et al. Birch-apple syndrome treated with birch pollen immunotherapy. Int Arch Allergy Immunol. 2011; 156:416–422. PMID: 21832831.

5. Eriksson NE, Wihl JA, Arrendal H. Birch pollen-related food hypersensitivity: influence of total and specific IgE levels. A multicenter study. Allergy. 1983; 38:353–357. PMID: 6614407.

6. Rodriguez J, Crespo JF, Lopez-Rubio A, De La Cruz-Bertolo J, Ferrando-Vivas P, Vives R, et al. Clinical cross-reactivity among foods of the Rosaceae family. J Allergy Clin Immunol. 2000; 106(1 Pt 1):183–189. PMID: 10887323.

7. Möller C. Effect of pollen immunotherapy on food hypersensitivity in children with birch pollinosis. Ann Allergy. 1989; 62:343–345. PMID: 2705661.

8. Herrmann D, Henzgen M, Frank E, Rudeschko O, Jäger L. Effect of hyposensitization for tree pollinosis on associated apple allergy. J Investig Allergol Clin Immunol. 1995; 5:259–267.

9. Asero R. Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients. Clin Exp Allergy. 1998; 28:1368–1373. PMID: 9824409.

10. Bergmann KC, Wolf H, Schnitker J. Effect of pollen-specific sublingual immunotherapy on oral allergy syndrome: an observational study. World Allergy Organ J. 2008; 1:79–84. PMID: 23282323.

11. Bucher X, Pichler WJ, Dahinden CA, Helbling A. Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut. Allergy. 2004; 59:1272–1276. PMID: 15507095.

12. Ebisawa M, Ito K, Fujisawa T. Committee for Japanese Pediatric Guideline for Food Allergy, The Japanese Society of Pediatric Allergy and Clinical Immunology, The Japanese Society of Allergology. Japanese guidelines for food allergy 2017. Allergol Int. 2017; 66:248–264. PMID: 28285847.

13. Oppenheimer JJ, Nelson HS, Bock SA, Christensen F, Leung DY. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol. 1992; 90:256–262. PMID: 1500630.

14. Nurmatov U, Dhami S, Arasi S, Pajno GB, Fernandez-Rivas M, Muraro A, et al. Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis. Allergy. 2017; 72:1133–1147. PMID: 28058751.

15. Burks AW, Sampson HA, Plaut M, Lack G, Akdis CA. Treatment for food allergy. J Allergy Clin Immunol. 2018; 141:1–9. PMID: 29307409.

16. Feuille E, Nowak-Wegrzyn A. Allergen-specific immunotherapies for food allergy. Allergy Asthma Immunol Res. 2018; 10:189–206. PMID: 29676066.

17. Pajno GB, Fernandez-Rivas M, Arasi S, Roberts G, Akdis CA, Alvaro-Lozano M, et al. EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy. Allergy. 2018; 73:799–815. PMID: 29205393.

18. Okamoto Y, Kurihara K. [A case of oral allergy syndrome whose symptoms were dramatically improved after rush subcutaneous injection immunotherapy with pollen extracts of birch]. Arerugi. 2012; 61:652–658. PMID: 22705787.

19. Kinaciyan T, Jahn-Schmid B, Radakovics A, Zwölfer B, Schreiber C, Francis JN, et al. Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1. J Allergy Clin Immunol. 2007; 119:937–943. PMID: 17204315.

20. Hansen KS, Khinchi MS, Skov PS, Bindslev-Jensen C, Poulsen LK, Malling HJ. Food allergy to apple and specific immunotherapy with birch pollen. Mol Nutr Food Res. 2004; 48:441–448. PMID: 15508179.

21. Nelson HS. Injection immunotherapy for inhalant allergens. In : Adkins NF, Bochner BS, Burks W, Busse WW, Holgate ST, Remanske RF, editors. Middleton's allergy priciple and practice. Philadelphia (PA): Elsevier Saunder;2014. p. 1416–1437.

22. Asero R. Effects of birch pollen SIT on apple allergy: a matter of dosage? Allergy. 2004; 59:1269–1271. PMID: 15507094.

23. Frew AJ, Powell RJ, Corrigan CJ, Durham SR. UK Immunotherapy Study Group. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2006; 117:319–325. PMID: 16461133.

24. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev. 2007; CD001936. PMID: 17253469.

25. Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zahman H, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systemtatic review and meta-analysis. Allergy. 2017; 72:1597–1631. PMID: 28493631.

26. Cho YS, Lim YJ, Lee JC, Kim SH, Lim MK, Yoo B, et al. Oral allergy syndrome in pollen-sensitized patients. J Asthma Allergy Clin Immunol. 1998; 18:458–465.

27. Park KH, Son YW, Lee SC, Jeong K, Sim da W, Park HJ, et al. Clinical significance of component allergens in Fagales pollen-sensitized peanut allergy in Korea. Allergy Asthma Immunol Res. 2016; 8:505–511. PMID: 27582401.

28. Park HS, Chung DH, Joo YJ. Survey of airborne pollens in Seoul, Korea. J Korean Med Sci. 1994; 9:42–46. PMID: 8068217.

29. Oh JW, Lee HB, Kang IJ, Kim SW, Park KS, Kook MH, et al. The revised edition of Korean calendar for allergenic pollens. Allergy Asthma Immunol Res. 2012; 4:5–11. PMID: 22211164.

30. Jeong KY, Son M, Park JH, Park KH, Park HJ, Lee JH, et al. Cross-reactivity between oak and birch pollens in Korean tree pollinosis. J Korean Med Sci. 2016; 31:1202–1207. PMID: 27478329.

31. Hauser M, Asam C, Himly M, Palazzo P, Voltolini S, Montanari C, et al. Bet v 1-like pollen allergens of multiple Fagales species can sensitize atopic individuals. Clin Exp Allergy. 2011; 41:1804–1814. PMID: 22092996.